Ranibizumab Biosimilar (Razumab) vs Innovator Ranibizumab (Lucentis) in neovascular age-related macular degeneration (n-AMD)- efficacy and safety (BIRA study)
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Bandello, Baruch D. Kuppermann, Anat Loewenstein
Topics & Concepts
RanibizumabMacular degenerationMedicineOphthalmologyBiosimilarInnovatorNeuro-ophthalmologyOptometryBevacizumabGlaucomaSurgeryInternal medicineComputer scienceChemotherapyIntellectual propertyOperating systemBiosimilars and Bioanalytical MethodsHealth Systems, Economic Evaluations, Quality of LifeRetinal and Optic Conditions